Search - tctmd.com

Displaying 501 - 520 of 1179

Sort: Relevancy | Date

News Daily News

Bridging Therapy for A-fib Patients Fails to Prevent Thromboembolism, Increases Bleeding

Yael L. Maxwell

July 10, 2015

News Industry News

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

July 09, 2015

News Industry News

Regeneron and Sanofi Announce Phase 3 Results Showing LDL-C Reductions of More Than 60 Percent in Japanese Patients Treated with Praluent® (alirocumab) Injection

July 09, 2015

News Industry News

CryoLife Receives Expanded Indication for BioGlue® in Japan

July 09, 2015

News Industry News

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

July 07, 2015

News Daily News

Updated Stroke Guidelines Back the Use of Stent Retrievers in Select Patients

July 01, 2015

News Daily News

FDA Approval of Cangrelor Expands Antiplatelet Options for PCI

Todd Neale

June 29, 2015

News Daily News

Method Chosen to Estimate Pre-PCI Kidney Function Matters

L.A. McKeown

June 29, 2015

News Industry News

U.S. to vie with India for top bioabsorbable stent market after FDA approval

June 25, 2015

News Daily News

RE-VERSE AD: Dabigatran Antidote Appears Safe, Effective in Interim Analysis

June 25, 2015

News Daily News

ICDs Often Not Given to Older Patients After Acute MI, Outcomes Suffer

Todd Neale

June 25, 2015

News Industry News

FDA approves new antiplatelet drug used during heart procedure

June 24, 2015

News Daily News

Data Submitted to FDA in Support of Cardiovascular Devices Often Differ From Those Published in Peer-Reviewed Papers

L.A. McKeown

June 22, 2015

News Industry News

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

June 19, 2015

News Daily News

在2项新的研究中均有挥之不去的PPI的潜在心血管风险

June 18, 2015

News Daily News

Possible Cardiovascular Risk of PPIs Lingers in 2 New Studies

June 18, 2015

News Industry News

One-Year Outcomes Data on Stroke Prevention in Patients With Newly Diagnosed Atrial Fibrillation (AF) to Be Presented at ISTH 2015

June 18, 2015

News Daily News

El Posible Riesgo Cardiovascular de los IBP se Mantiene en 2 Nuevos Estudios

June 18, 2015

Presentation

Concomitant PPI Use, Platelet Activity, and Clinical Outcomes in ACS Patients Treated With Prasugrel vs Clopidogrel and Managed Without Revascularization

Presenter: Jose Carlos Nicolau

June 17, 2015

News Industry News

GORE® EXCLUDER® Conformable AAA Endoprosthesis Receives Approval for Clinical Study in the US and Japan

June 16, 2015

Advertisement

Bridging Therapy for A-fib Patients Fails to Prevent Thromboembolism, Increases Bleeding

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

Regeneron and Sanofi Announce Phase 3 Results Showing LDL-C Reductions of More Than 60 Percent in Japanese Patients Treated with Praluent® (alirocumab) Injection

CryoLife Receives Expanded Indication for BioGlue® in Japan

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

Updated Stroke Guidelines Back the Use of Stent Retrievers in Select Patients

FDA Approval of Cangrelor Expands Antiplatelet Options for PCI

Method Chosen to Estimate Pre-PCI Kidney Function Matters

U.S. to vie with India for top bioabsorbable stent market after FDA approval

RE-VERSE AD: Dabigatran Antidote Appears Safe, Effective in Interim Analysis

ICDs Often Not Given to Older Patients After Acute MI, Outcomes Suffer

FDA approves new antiplatelet drug used during heart procedure

Data Submitted to FDA in Support of Cardiovascular Devices Often Differ From Those Published in Peer-Reviewed Papers

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

在2项新的研究中均有挥之不去的PPI的潜在心血管风险

Possible Cardiovascular Risk of PPIs Lingers in 2 New Studies

One-Year Outcomes Data on Stroke Prevention in Patients With Newly Diagnosed Atrial Fibrillation (AF) to Be Presented at ISTH 2015

El Posible Riesgo Cardiovascular de los IBP se Mantiene en 2 Nuevos Estudios

Concomitant PPI Use, Platelet Activity, and Clinical Outcomes in ACS Patients Treated With Prasugrel vs Clopidogrel and Managed Without Revascularization

GORE® EXCLUDER® Conformable AAA Endoprosthesis Receives Approval for Clinical Study in the US and Japan

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content